The startup manufactures a diagnostic reader device that delivers real-time reporting of biomarkers and pathogens, enabling rapid identification of diseases. By providing affordable diagnostics and integrated software for hospital management systems, the company enhances disease prevention efforts in a sustainable manner.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current rapid diagnostic tests often rely on subjective visual interpretation, leading to potential human error and inconsistencies in results. This can result in misdiagnosis and delayed or inappropriate treatment, especially in settings with limited resources or high testing volumes. The lack of quantitative data also hinders effective disease surveillance and outbreak tracking.
Solution
Assaya provides a rapid diagnostic platform that combines a universal reader device (iaX) with associated consumables and a cloud-based bioinformatics portal (assayaDX) to deliver accurate, quantitative results for a wide range of rapid diagnostic tests. The iaX reader can analyze lateral flow assays from any manufacturer, eliminating human error and providing standardized, objective results in seconds. The assayaDX portal enables real-time reporting, data analysis, and secure integration with laboratory information management systems (LIMS) and other healthcare IT systems. This integrated solution facilitates decentralized diagnostics, enabling testing in diverse environments such as hospitals, clinics, point-of-care settings, and field locations, while ensuring data integrity and patient privacy.
Target Audience
The primary target audience includes healthcare providers, hospitals, clinics, public health organizations, and research institutions seeking accurate, reliable, and scalable rapid diagnostic solutions for disease detection and monitoring.
Features
- Universal compatibility with lateral flow assays from various manufacturers
- Rapid, quantitative results in seconds, eliminating subjective visual interpretation
- Cloud-based assayaDX portal for real-time reporting, data analysis, and LIMS integration
- Secure, encrypted data transmission and storage to protect patient privacy
- Portable, ruggedized design for use in diverse environments
- Low Environmental Impact Quantitative Assay (LEIQA) test kits utilizing recyclable materials
- Integration with Assaya eXpress Progressive Web App (PWA) for instant results and cross-device access
- API access for custom data models, visualizations, and integrations